Cancer gene therapy: historical perspectives, current applications, and future directions

Area of Science:

• Oncology
• Molecular Biology
• Biotechnology

Background:

• Gene therapy represents a significant advancement in precision cancer treatment.
• Early gene therapy faced limitations in vector delivery efficiency, immune responses, and clinical efficacy.
• Historical challenges included <5% tumor transduction rates and <10% objective response rates.

Purpose of the Study:

• To review the evolution of gene therapy in cancer treatment.
• To highlight key milestones, current applications, and future directions.
• To explore the potential of gene therapy to revolutionize oncology.

Main Methods:

• Review of historical and current gene therapy strategies for cancer.
• Analysis of advancements in viral and non-viral vectors (e.g., AAVs).
• Inclusion of gene editing technologies like CRISPR-Cas9 and RNA interference.
• Examination of therapeutic approaches including gene restoration, oncogene silencing, and immune modulation.

Main Results:

• Significant improvements in vector transduction efficiency (e.g., AAVs >50% in solid tumors).
• CRISPR-Cas9 demonstrates high target gene knockout rates (90% in preclinical models).
• Current gene therapy strategies show promising clinical outcomes in cancer patients.
• Overcoming challenges like off-target effects and high costs remains crucial.

Conclusions:

• Gene therapy has transformed cancer treatment, moving beyond early limitations.
• Emerging innovations like personalized gene editing and oncolytic viruses signal a paradigm shift.
• Continued research and development are essential to realize the full therapeutic potential of gene therapy in oncology.